Investing

Vaxart : VXRT

VXRT

Stock Data

$0.77

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Vaxart Inc is a trailblazing biotech firm focused on revolutionizing vaccines by making them available in oral tablet form, rather than traditional injections. This innovative approach is being applied to a range of infectious diseases, including norovirus, seasonal influenza, respiratory syncytial virus, coronavirus, and human papillomavirus (HPV), with several vaccines currently undergoing clinical trials. Based in South San Francisco, California, Vaxart's mission is to enhance vaccine accessibility and acceptance worldwide.

All Vaxart Articles

4 Articles

Lee Jackson | Jun 26, 2021 at 9:04 AM EDT

5 Sizzling Stocks To Buy Now Trading Under $10 With Massive Upside Potential

Here's a look at five stocks, all with serious analyst coverage, currently selling for less than $10 a share.

Chris Lange | Jun 11, 2021 at 11:45 AM EDT

Nasdaq, Smartsheet, Twilio, Vaxart, Zoom Video and More Friday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Celsius, Nasdaq,…

Jon C. Ogg | Aug 6, 2020 at 6:13 PM EDT

13 Top After-Hours Earnings & News Movers for Thursday, Stocks to Watch for Friday

Earnings season may have peaked, but there are still many companies reporting earnings that are making big moves up or…

Chris Lange | Oct 4, 2018 at 1:45 PM EDT

Why Vaxart’s New Flu Vaccine Is So Great

Vaxart shares more than doubled on Thursday after the company announced positive results from the midstage trial of its influenza…